428 related articles for article (PubMed ID: 11413508)
21. Prevalence, characteristics and prognostic significance of anemia in daily practice.
Terrier B; Resche-Rigon M; Andres E; Bonnet F; Hachulla E; Marie I; Rosenthal E; Cacoub P;
QJM; 2012 Apr; 105(4):345-54. PubMed ID: 22119918
[TBL] [Abstract][Full Text] [Related]
22. Anemia in oncology practice: relation to diseases and their therapies.
Tas F; Eralp Y; Basaran M; Sakar B; Alici S; Argon A; Bulutlar G; Camlica H; Aydiner A; Topuz E
Am J Clin Oncol; 2002 Aug; 25(4):371-9. PubMed ID: 12151968
[TBL] [Abstract][Full Text] [Related]
23. Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF).
Dunst J; Becker A; Lautenschläger C; Markau S; Becker H; Fischer K; Haensgen G
Strahlenther Onkol; 2002 Aug; 178(8):436-41. PubMed ID: 12240549
[TBL] [Abstract][Full Text] [Related]
24. Impact of anemia in patients with head and neck cancer.
Kumar P
Oncologist; 2000; 5 Suppl 2():13-8. PubMed ID: 10896324
[TBL] [Abstract][Full Text] [Related]
25. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
26. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
[TBL] [Abstract][Full Text] [Related]
27. Preoperative anemia and perioperative blood transfusion in head and neck squamous cell carcinoma.
Baumeister P; Canis M; Reiter M
PLoS One; 2018; 13(10):e0205712. PubMed ID: 30347001
[TBL] [Abstract][Full Text] [Related]
28. Preoperative Anemia as a Simple Prognostic Factor in Patients with Urinary Bladder Cancer.
Chen C; Hu L; Li X; Hou J
Med Sci Monit; 2017 Jul; 23():3528-3535. PubMed ID: 28723884
[TBL] [Abstract][Full Text] [Related]
29. Anemia, tumor hypoxemia, and the cancer patient.
Varlotto J; Stevenson MA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):25-36. PubMed ID: 16111569
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
Dietl B; Marienhagen J; Schäfer C; Kölbl O
Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietic agents in the management of cancer patients. Part 1: Anemia, quality of life, and possible effects on survival.
Smith RE
J Support Oncol; 2003; 1(4):249-56, 258-9; discussion 257-8. PubMed ID: 15334867
[TBL] [Abstract][Full Text] [Related]
32. Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes.
Cella D; Dobrez D; Glaspy J
Ann Oncol; 2003 Apr; 14(4):511-9. PubMed ID: 12649095
[TBL] [Abstract][Full Text] [Related]
33. Anemia as an independent prognostic factor for survival in patients with cancer.
Watine J; Bouarioua N
Cancer; 2002 May; 94(10):2793-6; author reply 2796-7. PubMed ID: 12173350
[No Abstract] [Full Text] [Related]
34. [Relationship between anemia and clinical features and prognosis of advanced lung cancer patients].
Wang L; Shao ZH
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):512-516. PubMed ID: 30060359
[No Abstract] [Full Text] [Related]
35. Effect of pretreatment anemia on treatment outcome of concurrent radiochemotherapy in patients with head and neck cancer.
Fortin A; Wang CS; Vigneault E
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):255-60. PubMed ID: 18632214
[TBL] [Abstract][Full Text] [Related]
36. The role of the Patient-Generated Subjective Global Assessment (PG-SGA) and biochemical markers in predicting anemia patients with cancer.
Wu M; Lian XJ; Jia JM; Cao WT; Yan N; Xin YM; Liu ZR; Li HY; Fan ZF; Sun P
Support Care Cancer; 2019 Apr; 27(4):1443-1448. PubMed ID: 30206725
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
Ludwig H; Sundal E; Pecherstorfer M; Leitgeb C; Bauernhofer T; Beinhauer A; Samonigg H; Kappeler AW; Fritz E
Cancer; 1995 Dec; 76(11):2319-29. PubMed ID: 8635038
[TBL] [Abstract][Full Text] [Related]
38. The causes and prognostic significance of low hemoglobin levels in tumor patients.
Manegold C
Strahlenther Onkol; 1998 Dec; 174 Suppl 4():17-9. PubMed ID: 9879342
[TBL] [Abstract][Full Text] [Related]
39. Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neck.
Shenouda G; Zhang Q; Ang KK; Machtay M; Parliament MB; Hershock D; Suntharalingam M; Lin A; Rotman M; Nabid A; Hong S; Shehata S; Cmelak AJ; Sultanem K; Le QT
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):907-15. PubMed ID: 25670542
[TBL] [Abstract][Full Text] [Related]
40. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
